These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27235213)

  • 21. Risks and benefits of prophylactic cyclic parenteral nutrition in surgical neonates.
    Nghiem-Rao TH; Cassidy LD; Polzin EM; Calkins CM; Arca MJ; Goday PS
    Nutr Clin Pract; 2013 Dec; 28(6):745-52. PubMed ID: 24107391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes.
    Andorsky DJ; Lund DP; Lillehei CW; Jaksic T; Dicanzio J; Richardson DS; Collier SB; Lo C; Duggan C
    J Pediatr; 2001 Jul; 139(1):27-33. PubMed ID: 11445790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled trial of slow vs rapid enteral feeding advancements on the clinical outcomes of preterm infants with birth weight 750-1250 g.
    Karagol BS; Zenciroglu A; Okumus N; Polin RA
    JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):223-8. PubMed ID: 22664861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
    Gura KM; Duggan CP; Collier SB; Jennings RW; Folkman J; Bistrian BR; Puder M
    Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical intervention in the setting of parenteral nutrition-associated cholestasis may exacerbate liver injury.
    Arsenault DA; Potemkin AK; Robinson EM; Fallon EM; Ozonoff A; de Meijer VE; Puder M
    J Pediatr Surg; 2011 Jan; 46(1):122-7. PubMed ID: 21238652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Factors derived from parenteral nutrition associated with cholestasis in 612 neonates].
    Tang QY; Wang Y; Feng Y; Tao YX; Wu J; Cai W
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):838-42. PubMed ID: 18282416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis and treatment of parenteral nutrition-associated liver disease.
    Xu ZW; Li YS
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):586-93. PubMed ID: 23232629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors for parenteral nutrition-associated cholestasis in neonates].
    Feng Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):670-3. PubMed ID: 25008870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome.
    Fitzgibbons SC; Jones BA; Hull MA; Zurakowski D; Duro D; Duggan C; Boctor D; Sigalet DL; Jaksic T
    J Pediatr Surg; 2010 Jan; 45(1):95-9; discussion 99. PubMed ID: 20105587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.
    Bishay M; Pichler J; Horn V; Macdonald S; Ellmer M; Eaton S; Hill S; Pierro A
    J Pediatr Surg; 2012 Feb; 47(2):359-62. PubMed ID: 22325390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in Enteral Feeding Practices and Growth Outcomes among Very Premature Infants: A Report from the New York State Perinatal Quality Collaborative.
    Stevens TP; Shields E; Campbell D; Combs A; Horgan M; La Gamma EF; Xiong K; Kacica M
    Am J Perinatol; 2016 Jan; 33(1):9-19. PubMed ID: 26084749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of protein/nonprotein caloric intake on parenteral nutrition associated cholestasis in premature infants weighing 600-1000 grams.
    Blau J; Sridhar S; Mathieson S; Chawla A
    JPEN J Parenter Enteral Nutr; 2007; 31(6):487-90. PubMed ID: 17947604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
    Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.
    Calkins KL; Havranek T; Kelley-Quon LI; Cerny L; Flores M; Grogan T; Shew SB
    JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):404-411. PubMed ID: 26024828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parenteral-nutrition-associated liver disease after intestinal perforation in extremely low-birthweight infants: consequent lethal portal hypertension.
    Kubota A; Mochizuki N; Shiraishi J; Nakayama M; Kawahara H; Yoneda A; Tazuke Y; Goda T; Nakahata K; Sano H; Hirano S; Kitajima H
    Pediatr Int; 2013 Feb; 55(1):39-43. PubMed ID: 23240986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperalimentation-induced cholestasis. Increased incidence and severity in premature infants.
    Pereira GR; Sherman MS; DiGiacomo J; Ziegler M; Roth K; Jacobowski D
    Am J Dis Child; 1981 Sep; 135(9):842-5. PubMed ID: 6792907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Parenteral nutrition-associated liver disease].
    Moreno Villares JM
    Nutr Hosp; 2008 May; 23 Suppl 2():25-33. PubMed ID: 18714408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants.
    Jakobsen MS; Jørgensen MH; Husby S; Andersen L; Jeppesen PB
    Dig Dis Sci; 2015 Jan; 60(1):252-9. PubMed ID: 25107446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets.
    Guthrie G; Stoll B; Chacko S; Lauridsen C; Plat J; Burrin D
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G41-G52. PubMed ID: 31604032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.